COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ECUADOR

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Future Performance Dependent on Government Restrictions

Self-medication Common in This Category

the Natural Trend Having A Growing Influence on the Category

Competitive Landscape

Roemmers Maintains Its Lead

Environmental Factors Support Sales

International Brands Lead

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Remains Stable

Consumer Health Growth Driven by Health and Wellness Trend

International Companies Continue To Lead Consumer Health

Internet Retailing Gains Relevance, Albeit With Minimal Penetration

Slow Growth Expected Over the Forecast Period

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Distribution of Consumer Health by Format: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format and Category: % Value 2018

Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

In order to control influenza and H1N1 flu cases, which increased in the first half of 2016, government restrictions were reapplied in April 2016 on those medicines containing the active ingredients acetaminophen (paracetamol) or ibuprofen and those with associated active ingredients such as ibuprofen-paracetamol, ibuprofen-caffeine, paracetamol-caffeine and paracetamol-bicarbonate-citric acid in other cold and cough remedies. This has limited category growth, but it may record higher growth ove...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Ecuador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.